Sensus Healthcare, Inc.

Sensus Healthcare, Inc.

SRTSยทNASDAQ

$3.09

-2.8%
HealthcareMedical - Devices

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

At a Glance

Live Snapshot
Market Cap$50.87M
EPS-0.4700
P/E Ratio-8.42
Earnings Date07/30/2026
-17.02%
Return on Invested Capital
-261%
3Y-165.0%
5Y-52.0%
10Y+617.0%
-16.05%
Return on Equity
-235%
3Y-132.0%
5Y-50.0%
10Y+608.0%
-14.55%
Return on Assets
-236%
3Y-134.0%
5Y-40.0%
10Y+696.0%
Sensus Healthcare, Inc.

Sensus Healthcare, Inc. Management Team

SRTS ยท NASDAQ
MJ

Mr. Javier Rampolla

Chief Financial Officer

Compensation

$656,045

Born 1973(Age 53)
male
MM

Ms. Magdalena Martinez

Chief Operating Officer

Born 1990(Age 36)
female
ME

Mr. Emiliano Sosa

Chief Technology Officer

Born 1978(Age 48)
male
MJ

Mr. Joseph C. Sardano

Co-Founder, Chairman & Chief Executive Officer

Compensation

$1,268,030

Born 1953(Age 73)
male
MM

Mr. Michael J. Sardano J.D.

President, General Counsel, Corporate Secretary & Director

Compensation

$910,878

Born 1988(Age 38)
male
MS

Ms. Stephanie Tipton

Vice President of Marketing

female
srts

Sensus Healthcare, Inc. Insider Positioning

SRTS ยท NASDAQ

During the last 12 months, insiders have purchased $166K worth of SRTS shares, with no selling activity reported.

3 Months

Bought

1.5K

5.00K

Sold

0

0.00

Net Activity

+5K

+$5K

3-6 Months

Bought

2.0K

7.62K

Sold

0

0.00

Net Activity

+8K

+$8K

6-9 Months

Bought

37.0K

149.58K

Sold

0

0.00

Net Activity

+150K

+$150K

9-12 Months

Bought

1.0K

3.37K

Sold

0

0.00

Net Activity

+3K

+$3K

Top Buyers

1
SJC

Sardano Joseph C

Director, Officer: Chief Executive Officer

25.0K sharesโ€ข1 transactions

$101K

2
SE

Sachetta Eric

Director

13.0K sharesโ€ข4 transactions

$51K

3
SM

Sardano Michael

Director, Officer: President And General Counsel

3.5K sharesโ€ข5 transactions

$13K

Top Sellers

No selling activity

Insider Activity Analysis

Net Insider Sentiment

Bullish

Strong bullish signal with $166K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.

Buy/Sell Ratio

โˆž:1

Perfect buy/sell ratio. Only buying activity with zero sellingโ€”the most bullish possible insider signal.

Recent Trend (3 Months)

$5K

Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.

Insider Participation

High Buying

3 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.

Insider Activity Insight

Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.

SEC Filings

SRTS - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

April 29, 2026
May 29, 2026
2026
DEF 14A

DEF 14A 2025

N/A

April 29, 2025
May 27, 2025
2025
DEF 14A

DEF 14A 2024

N/A

April 29, 2024
May 31, 2024
2024
DEF 14A

DEF 14A 2023

N/A

May 01, 2023
June 02, 2023
2023
DEF 14A

DEF 14A 2022

N/A

April 29, 2022
June 03, 2022
2022
DEF 14A

DEF 14A 2021

N/A

April 30, 2021
June 04, 2021
2021
DEF 14A

DEF 14A 2020

N/A

April 29, 2020
June 05, 2020
2020
DEF 14A

DEF 14A 2019

N/A

April 26, 2019
June 07, 2019
2019
DEF 14A

DEF 14A 2018

N/A

April 26, 2018
June 08, 2018
2018
DEF 14A

DEF 14A 2017

N/A

April 21, 2017
June 05, 2017
2017
Showing 1 to 10 of 10 filings